Ligneous conjunctivitis in a patient with Crohn′s disease
Graciana Fuentes-Páez1, José M Herreras1, M del C Méndez2, MA Saorni1,2
1Ocular Immunology and Uveitis Unit, Institute of Ophthalmobiology (IOBA), University of Valladolid, Valladolid, Spain and Hospital Universitario de Valladolid, Spain; 2Ocular Pathology and Lab Registry “Miguel N. Burnier”, Institute of Ophthalmobiology (IOBA), University of Valladolid, Valladolid, Spain
Objective: Report the case of a patient with Crohn´s disease and ligneous conjunctivitis.
Methods: Interventional case report of a 27-year old female patient, with a 4-year history of Crohn´s disease, was seen for right eye conjunctival ulcer after resolved chemical trauma. Conjunctival biopsy was performed for histopathology, immunofluorescence microscopy, and immunohistochemistry testing.
Results: Microbiology tests were negative for bacteria and fungi. PCR was negative for atypical mycobacteria and Herpes. Ocular Crohn´s disease, Whipple disease, and amyloidosis were ruled out. Immunofluorescence microscopy revealed characteristic IgG κ and λ light chain deposits, and fibrin deposition was confirmed through Lendrum´s Martius, Scarlet, and Blue technique. Endogenous plasminogen levels were normal. Recurrent ulcers did not resolve after treatment with infliximab, but only after four surgeries, topical steroids, 1% cyclosporine, heparin (5000 units/ml), and hyaluronidase (1.5 mg/ml). After 9 months of follow-up, nasal symblepharon was observed as sequela.
Conclusions: We report the case of a patient with unilateral ligneous conjunctivitis, triggered by chemical injury, and Crohn´s disease.
Keywords: Crohn´s disease, immunofluorescence microscopy, ligneous conjunctivitis, plasminogen, ulcerative conjunctivitis
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Readers of this article also read:
Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
Milani P, Massacesi A, Ciaccia S, Setaccioli M, Moschini S, Bergamini F
Published Date: 19 November 2012
Synthesis and properties of a novel biodegradable poly(ester amine) copolymer based on poly(L-lactide) and low molecular weight polyethylenimine for gene delivery
Guo QF, Liu TT, Yan X, Wang XH, Shi S, Luo F, Qian ZY
Published Date: 11 August 2011
Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N
Published Date: 21 July 2011
Payne CM, Crowley-Skillicorn C, Bernstein C, Holubec H, Bernstein H
Published Date: 3 May 2011
Eric Prommer, Lisa Thompson
Published Date: 18 March 2011
Peter Avery, Shaymaa S Mousa, Shaker A Mousa
Published Date: 13 September 2009
Samir Aziz, Alex Taylor, Andrzej McConnachie, Alex Kacperek, Ewan Kemp
Published Date: 28 August 2008
Amar Agarwal, Rupal H Trivedi, Soosan Jacob, Athiya Agarwal, Sunita Agarwal
Published Date: 3 December 2007
Scott G Fraser
Published Date: 30 November 2007